Cargando…
Mechanism underlying linezolid-induced peripheral neuropathy in multidrug-resistant tuberculosis
Multidrug-resistant tuberculosis (MDR-TB) remains a main global health concern as there is no comprehensive therapeutic intervention yet and numerous adverse effects follow the therapeutic process. In recent years, linezolid has been frequently used for treating MDR-TB. However, peripheral neuropath...
Autores principales: | Yuan, Yuan, Li, Jinmeng, Chen, Yanhong, Cai, Qingshan, Xu, Yingying, Lin, Luting, Lang, Yazhen, Guo, Suhang, Zhang, Ruoying, Cai, Xinjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500448/ https://www.ncbi.nlm.nih.gov/pubmed/36160387 http://dx.doi.org/10.3389/fphar.2022.946058 |
Ejemplares similares
-
Population pharmacokinetics and dose evaluations of linezolid in the treatment of multidrug-resistant tuberculosis
por: Zhang, Haoyue, et al.
Publicado: (2023) -
Linezolid resistance in multidrug-resistant mycobacterium tuberculosis: A systematic review and meta-analysis
por: Azimi, Taher, et al.
Publicado: (2022) -
Individualized Pharmaceutical Care for Antifungal Therapy in a Patient with Aspergillus tubingensis Spondylitis After Discontinuation of Rifampicin: A Case Report
por: Li, Jinmeng, et al.
Publicado: (2023) -
Pharmacokinetic analysis of linezolid for multidrug resistant tuberculosis at a tertiary care centre in Mumbai, India
por: Resendiz-Galvan, Juan Eduardo, et al.
Publicado: (2023) -
Peripheral neuropathy in a diabetic child treated with linezolid for multidrug-resistant tuberculosis: a case report and review of the literature
por: Swaminathan, Aravind, et al.
Publicado: (2017)